The global Transcatheter Embolization And Occlusion Devices Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Coil, Non Coil), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Others).
In 2025, the transcatheter embolization and occlusion devices market is thriving, supported by advancements in interventional radiology techniques, embolic agents, and the growing demand for minimally invasive treatment options for vascular malformations, tumor embolization, and hemorrhage control in oncology, interventional radiology, and neurovascular interventions. Transcatheter embolization and occlusion devices encompass a variety of embolic coils, liquid embolic agents, vascular plugs, and microspheres used to selectively occlude blood vessels, control blood flow, and induce thrombosis for the treatment of aneurysms, arteriovenous malformations (AVMs), and hemorrhagic lesions, providing patients with targeted and minimally invasive alternatives to traditional open surgeries. With innovations in embolic materials, detachable devices, and image-guided delivery systems, the market is experiencing rapid expansion and adoption of transcatheter embolization and occlusion devices, offering interventional radiologists, neurosurgeons, and oncologists safe and effective tools for vascular embolotherapy, tumor ablation, and hemorrhage management, driving advancements in minimally invasive vascular interventions and endovascular therapies.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across Abbott, Boston Scientific Corp, Cordis, DePuy Synthes, Medtronic, Nordion, Pfizer Inc, Sirtex, Stryker, Terumo Corp, and Others.
A significant trend in the transcatheter embolization and occlusion devices market is the rising adoption of minimally invasive procedures for the treatment of various medical conditions. Transcatheter embolization and occlusion techniques offer less invasive alternatives to traditional surgical approaches for controlling bleeding, blocking blood flow to tumors, treating vascular malformations, and managing aneurysms. This trend is fueled by advancements in device technology, imaging guidance, and procedural techniques, enabling physicians to perform complex interventions with greater precision and safety. As healthcare providers and patients seek minimally invasive treatment options that offer faster recovery, reduced complications, and improved outcomes, the demand for transcatheter embolization and occlusion devices continues to grow, supporting market expansion.
The increasing incidence of vascular disorders, such as peripheral artery disease (PAD), arteriovenous malformations (AVMs), and hepatic tumors, along with the growing prevalence of oncological conditions, serves as a significant driver for the transcatheter embolization and occlusion devices market. Transcatheter embolization and occlusion procedures play a critical role in the management of these conditions by blocking abnormal blood vessels, reducing blood flow to tumors, and preventing hemorrhage. Factors such as aging population, lifestyle changes, and advances in diagnostic imaging contribute to the rising burden of vascular and oncological diseases, driving the demand for effective interventional therapies. As healthcare providers strive to deliver personalized and minimally invasive treatment options to patients, the market for transcatheter embolization and occlusion devices is expected to experience continued growth.
The expanding applications of transcatheter embolization and occlusion devices in interventional oncology represent a promising opportunity for market growth. Interventional oncology encompasses minimally invasive procedures for the treatment of cancer, including transcatheter embolization of tumors, radioembolization, and chemoembolization. Transcatheter embolization and occlusion devices enable targeted delivery of therapeutic agents or embolic materials to tumors, resulting in tumor necrosis, symptom relief, and improved patient outcomes. With the growing demand for minimally invasive cancer treatments that complement traditional therapies, such as surgery, chemotherapy, and radiation therapy, there is an increasing need for innovative transcatheter devices tailored to the unique challenges of interventional oncology. Capitalizing on this opportunity requires collaboration between device manufacturers, interventional radiologists, and oncologists to develop specialized devices, expand clinical evidence, and enhance treatment outcomes in the rapidly evolving field of interventional oncology.
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
*List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Transcatheter Embolization And Occlusion Devices Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Transcatheter Embolization And Occlusion Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Transcatheter Embolization And Occlusion Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Transcatheter Embolization And Occlusion Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Transcatheter Embolization And Occlusion Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Transcatheter Embolization And Occlusion Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Transcatheter Embolization And Occlusion Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Transcatheter Embolization And Occlusion Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Transcatheter Embolization And Occlusion Devices Industry
4.2 Key Market Trends in Transcatheter Embolization And Occlusion Devices Industry
4.3 Potential Opportunities in Transcatheter Embolization And Occlusion Devices Industry
4.4 Key Challenges in Transcatheter Embolization And Occlusion Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Transcatheter Embolization And Occlusion Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Transcatheter Embolization And Occlusion Devices Market Outlook by Segments
7.1 Transcatheter Embolization And Occlusion Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
8 North America Transcatheter Embolization And Occlusion Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Transcatheter Embolization And Occlusion Devices Markets in 2024
8.2 North America Transcatheter Embolization And Occlusion Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Transcatheter Embolization And Occlusion Devices Market size Outlook by Segments, 2021-2030
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
9 Europe Transcatheter Embolization And Occlusion Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Transcatheter Embolization And Occlusion Devices Markets in 2024
9.2 Europe Transcatheter Embolization And Occlusion Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Transcatheter Embolization And Occlusion Devices Market Size Outlook by Segments, 2021-2030
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
10 Asia Pacific Transcatheter Embolization And Occlusion Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Transcatheter Embolization And Occlusion Devices Markets in 2024
10.2 Asia Pacific Transcatheter Embolization And Occlusion Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Transcatheter Embolization And Occlusion Devices Market size Outlook by Segments, 2021-2030
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
11 South America Transcatheter Embolization And Occlusion Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Transcatheter Embolization And Occlusion Devices Markets in 2024
11.2 South America Transcatheter Embolization And Occlusion Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Transcatheter Embolization And Occlusion Devices Market size Outlook by Segments, 2021-2030
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
12 Middle East and Africa Transcatheter Embolization And Occlusion Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Transcatheter Embolization And Occlusion Devices Markets in 2024
12.2 Middle East and Africa Transcatheter Embolization And Occlusion Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Transcatheter Embolization And Occlusion Devices Market size Outlook by Segments, 2021-2030
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Boston Scientific Corp
Cordis
DePuy Synthes
Medtronic
Nordion
Pfizer Inc
Sirtex
Stryker
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Coil
-Pushable Coils
-Detachable Coils
Non Coil
-Flow Diverting Devices
-Embolization Particles
-Liquid Embolics
-Others
-Accessories
By Application
Peripheral Vascular Disease
-Arterial Blockage
-Venous Blood clot
-Others
Oncology
-Liver cancer
-Pancreatic cancer
-Breast cancer
-Kidney cancer
-Others
Neurology
-Brain Aneurysm
-Cerebral arteriovenous malformations
-Others
Urology
-Benign prostatic hyperplasia/Urinary retention
-Others
Others
The Global Transcatheter Embolization And Occlusion Devices Market Size is estimated at $6.1 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 7.9% to reach $12.1 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Boston Scientific Corp, Cordis, DePuy Synthes, Medtronic, Nordion, Pfizer Inc, Sirtex, Stryker, Terumo Corp
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume